Found: 1 article

Article Edition
K.S. Grechukhina (1, 2), K.A. Vorontsova (1), T.M. Kuko (1), A.A. Prosvirnov (1), I.P. Ganshina (3), E.V. Lubennikova (3), I.V. Kolyadina (4, 5), L.G. Zhukova (1)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
№7 / 2021


Бионика Медиа